Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02994368 · ClinicalTrials.gov registry record
"Natural History" Study of Choroideremia
A clinical trial, sponsored by 4D Molecular Therapeutics.
- Terminated
- Registry status
- 57
- Enrollment target
NCT02994368 is a clinical trial that was terminated before completion, run by 4D Molecular Therapeutics. The registered enrollment target is 57 participants.
The verdict
NCT02994368 was terminated before completion, sponsored by 4D Molecular Therapeutics.
- TERMINATED
- Registry status
- 57 participants
- Enrollment target
Study Summary
The purpose of this study is to understand the rate of progression of all stages of choroideremia using a variety of assessments performed in the clinic including visual field measures, specialized photography of the eye and participant-reported visual problems
Interventions
- OTHER Observation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2016-12 |
| Est. Completion | 2021-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02994368
The ClinicalTrials.gov registry entry for NCT02994368 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is 4D Molecular Therapeutics, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Observation is the first listed.
NCT02994368 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02994368 about?
NCT02994368 is a clinical study titled ""Natural History" Study of Choroideremia". The purpose of this study is to understand the rate of progression of all stages of choroideremia using a variety of assessments performed in the clinic including visual field measures, specialized photography of the eye and participant-reported visual problems
What is the current status of trial NCT02994368?
This trial is currently terminated. The enrollment target is 57 participants. The study started on 2016-12. Estimated completion is 2021-10.
What interventions are being tested in trial NCT02994368?
The interventions under investigation include: Observation (OTHER).
Who is sponsoring clinical trial NCT02994368?
This trial is sponsored by 4D Molecular Therapeutics, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.